Annexin Pharmaceuticals (Sweden) Market Value
| ANNX Stock | SEK 0.54 0.06 12.50% |
| Symbol | Annexin |
Annexin Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Annexin Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Annexin Pharmaceuticals.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Annexin Pharmaceuticals on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Annexin Pharmaceuticals AB or generate 0.0% return on investment in Annexin Pharmaceuticals over 30 days. Annexin Pharmaceuticals is related to or competes with Cantargia, Biovica International, Ascelia Pharma, and BioArctic. Annexin Pharmaceuticals AB , a biotechnology company, engages in developing drug candidates for the treatment of various... More
Annexin Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Annexin Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Annexin Pharmaceuticals AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 23.14 | |||
| Value At Risk | (6.12) | |||
| Potential Upside | 8.33 |
Annexin Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Annexin Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Annexin Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Annexin Pharmaceuticals historical prices to predict the future Annexin Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (0.72) |
Annexin Pharmaceuticals Backtested Returns
Currently, Annexin Pharmaceuticals AB is out of control. Annexin Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0348, which signifies that the company had a 0.0348% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Annexin Pharmaceuticals AB, which you can use to evaluate the volatility of the firm. Please confirm Annexin Pharmaceuticals' Risk Adjusted Performance of (0.03), standard deviation of 4.66, and Mean Deviation of 3.49 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. Annexin Pharmaceuticals has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.37, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Annexin Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Annexin Pharmaceuticals is expected to be smaller as well. Annexin Pharmaceuticals right now shows a risk of 4.66%. Please confirm Annexin Pharmaceuticals information ratio, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Annexin Pharmaceuticals will be following its price patterns.
Auto-correlation | 0.37 |
Below average predictability
Annexin Pharmaceuticals AB has below average predictability. Overlapping area represents the amount of predictability between Annexin Pharmaceuticals time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Annexin Pharmaceuticals price movement. The serial correlation of 0.37 indicates that just about 37.0% of current Annexin Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.37 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Annexin Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Annexin Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Annexin Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Annexin Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Annexin Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Annexin Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Annexin Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Annexin Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Annexin Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Annexin Pharmaceuticals Lagged Returns
When evaluating Annexin Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Annexin Pharmaceuticals stock have on its future price. Annexin Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Annexin Pharmaceuticals autocorrelation shows the relationship between Annexin Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Annexin Pharmaceuticals AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Annexin Stock Analysis
When running Annexin Pharmaceuticals' price analysis, check to measure Annexin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annexin Pharmaceuticals is operating at the current time. Most of Annexin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Annexin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annexin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Annexin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.